Tag: Hatch-Waxman Act
Pediatric Exclusivity Explained: How the FDA Extends Drug Patent Protection
Learn how pediatric exclusivity allows the FDA to extend drug patent protection by six months. Discover the mechanics, strategic value, and impact on generics.
First-Mover Advantage: Why Being First to Market Wins for Generic Drug Makers
Discover how first-mover advantage shapes success for generic drug makers. Learn why timing matters, how the Hatch-Waxman Act works, and what strategies top companies use to stay ahead.
When Do Drug Patents Expire? Understanding the 20-Year Term and Real-World Timelines
Drug patents last 20 years from filing, but most drugs only have 7-12 years of real market exclusivity due to long approval times. Patent extensions, regulatory exclusivity, and litigation can delay generics for years.